What is a direct outcome of quality assurance in medical stores?

• A. Increase procurement costs
• B. Reduction of substandard or counterfeit drugs
• C. Longer storage times
• D. Fewer regulatory audits

Answer: (B)

Quality assurance in medical stores focuses on making sure medicines are safe, effective, and of the right quality before they reach patients. It covers supplier qualification, proper receiving and storage, accurate inventory and temperature control, and procedures for recalls and incident investigation. Because of these checks and controls, the most direct outcome is a reduction in substandard or counterfeit drugs making their way into the supply chain. When each batch is verified, packaging is checked, and suspect products are identified and removed, the risk of poor-quality medicines reaching patients drops.

Increasing procurement costs isn’t the aim of QA, even if there can be upfront expenses for better supplier auditing and quality testing. Longer storage times aren’t desirable because they can lead to degradation if not managed properly, which QA seeks to prevent through proper storage conditions and stock rotation. Fewer regulatory audits would undermine the integrity of QA; ongoing audits and compliance checks are a core part of maintaining quality, not a consequence of effective QA.